Rollover Study of BMS-354825 in Patients With CML and Ph+ALL

Clinical trial NCT01030718 · COMPLETED

Trial details

NCT number: NCT01030718
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chronic Myelogenous Leukemia Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Start date: 2006-01-01
Primary completion: 2009-06-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.